| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Common variable immune deficiency | 20 | 15 | |
| Hypogammaglobulinemia | 11 | 9 | |
| Chronic inflammatory demyelinating polyneuropathy | 4 | 14 | |
| IgG deficiency | 2 | 1 | |
| Specific antibody deficiency | 2 | 2 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Fatigue | 4 | |
| Headaches | 3 | |
| Injection site pain | 3 | |
| Injection site swelling | 3 | |
| Diarrhea | 2 | |
| Dizziness | 2 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 2 | |
| Moderate | 8 | |
| Mild | 25 | |
| None | 6 |